Chronic Inflammatory Response Syndrome (CIRS): A Review of Diagnosis, Immunological Mechanisms and Treatment Challenges
Chronic Inflammatory Response Syndrome (CIRS) is an emerging and controversial condition characterized by a multi-system, multi-symptom illness triggered primarily by biotoxin exposure, particularly from water-damaged buildings (WDB). First described by Dr. Ritchie Shoemaker, CIRS is thought to result from a genetically predisposed individual’s inability to eliminate biotoxins effectively, leading to chronic immune activation. Despite increasing patient reports and clinical attention, CIRS remains a contentious diagnosis due to its complex symptomatology, lack of standardized diagnostic criteria, and limited recognition in mainstream medicine. This review aims to explore the underlying immunological mechanisms, examine the diagnostic challenges and controversies, and highlight the significant treatment gaps that impede effective management. A growing body of evidence supports the biological plausibility of CIRS, particularly involving innate immune dysregulation, complement activation, and cytokine imbalances. However, further research, standardized guidelines, and consensus in the medical community are urgently needed to validate and manage this debilitating condition.